[1]
QADDOORI, Y.B. et al. 2024. The Potential Role of HDAC1 and HDAC3 Immunoexpression in P53 Downregulation and Tumor Aggressiveness of Colon and Rectum Carcinomas Patients. Experimental Oncology. 46, 4 (Dec. 2024), 393–401. DOI:https://doi.org/10.15407/exp-oncology.2024.04.393.